Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 25 to 36 of 222 entries
Sorted by: Best Match Show Resources per page
Acute kidney injury in Staphylococcus aureus bacteremia.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology

Westgeest AC, Schippers EF, Delfos NM, Visser LG, de Fijter JW, de Boer MGJ, Lambregts MMC.
PMID: 34993670
Eur J Clin Microbiol Infect Dis. 2022 Jan 07; doi: 10.1007/s10096-021-04391-3. Epub 2022 Jan 07.

Acute kidney injury (AKI) is a frequent complication in patients with Staphylococcus aureus bacteremia (SAB), with a significant impact on patient management and outcome. This study aimed to provide insight in the proportion of patients with SAB that develop...

Cite
Westgeest AC, Schippers EF, Delfos NM, et al. Acute kidney injury in Staphylococcus aureus bacteremia. Eur J Clin Microbiol Infect Dis. 2022;doi: 10.1007/s10096-021-04391-3.
Westgeest, A. C., Schippers, E. F., Delfos, N. M., Visser, L. G., de Fijter, J. W., de Boer, M. G. J., & Lambregts, M. M. C. (2022). Acute kidney injury in Staphylococcus aureus bacteremia. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, . https://doi.org/10.1007/s10096-021-04391-3
Westgeest, Annette C, et al. "Acute kidney injury in Staphylococcus aureus bacteremia." European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology vol. (2022). doi: https://doi.org/10.1007/s10096-021-04391-3
Westgeest AC, Schippers EF, Delfos NM, Visser LG, de Fijter JW, de Boer MGJ, Lambregts MMC. Acute kidney injury in Staphylococcus aureus bacteremia. Eur J Clin Microbiol Infect Dis. 2022 Jan 07; doi: 10.1007/s10096-021-04391-3. Epub 2022 Jan 07. PMID: 34993670.
Copy Download .nbib Format: NLM
Therapeutic failures of targeted antibiotic prophylaxis in urology.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology

Curlier E, Sadreux Y, Markowicz S, Brureau L, Donat S, Blanchet P, Roger PM.
PMID: 34787746
Eur J Clin Microbiol Infect Dis. 2021 Nov 17; doi: 10.1007/s10096-021-04329-9. Epub 2021 Nov 17.

Targeted antibiotic prophylaxis (TAP) is required for patients with positive urine culture before urological surgery. Our aim was to determine the efficacy of TAP. This was a prospective single-center study performed in a urology department. All patients who underwent...

Cite
Curlier E, Sadreux Y, Markowicz S, et al. Therapeutic failures of targeted antibiotic prophylaxis in urology. Eur J Clin Microbiol Infect Dis. 2021;doi: 10.1007/s10096-021-04329-9.
Curlier, E., Sadreux, Y., Markowicz, S., Brureau, L., Donat, S., Blanchet, P., & Roger, P. M. (2021). Therapeutic failures of targeted antibiotic prophylaxis in urology. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, . https://doi.org/10.1007/s10096-021-04329-9
Curlier, Elodie, et al. "Therapeutic failures of targeted antibiotic prophylaxis in urology." European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology vol. (2021). doi: https://doi.org/10.1007/s10096-021-04329-9
Curlier E, Sadreux Y, Markowicz S, Brureau L, Donat S, Blanchet P, Roger PM. Therapeutic failures of targeted antibiotic prophylaxis in urology. Eur J Clin Microbiol Infect Dis. 2021 Nov 17; doi: 10.1007/s10096-021-04329-9. Epub 2021 Nov 17. PMID: 34787746.
Copy Download .nbib Format: NLM
Interplay between IncF plasmids and topoisomerase mutations conferring quinolone resistance in the Escherichia coli ST131 clone: stability and resistance evolution.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology

Rodríguez-Martínez JM, Lopez-Cerero L, García-Duque A, Rodriguez-Baño J, Pascual A.
PMID: 34787748
Eur J Clin Microbiol Infect Dis. 2021 Nov 17; doi: 10.1007/s10096-021-04358-4. Epub 2021 Nov 17.

The Escherichia coli ST131 H30-Rx subclone vehicles CTX-M-15 plasmids and mutations in gyrA and parC conferring multidrug resistance successfully in the clinical setting. The aim of this study was (1) to investigate the relationship of specific topoisomerase mutations on...

Cite
Rodríguez-Martínez JM, Lopez-Cerero L, García-Duque A, et al. Interplay between IncF plasmids and topoisomerase mutations conferring quinolone resistance in the Escherichia coli ST131 clone: stability and resistance evolution. Eur J Clin Microbiol Infect Dis. 2021;doi: 10.1007/s10096-021-04358-4.
Rodríguez-Martínez, J. M., Lopez-Cerero, L., García-Duque, A., Rodriguez-Baño, J., & Pascual, A. (2021). Interplay between IncF plasmids and topoisomerase mutations conferring quinolone resistance in the Escherichia coli ST131 clone: stability and resistance evolution. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, . https://doi.org/10.1007/s10096-021-04358-4
Rodríguez-Martínez, Jose-Manuel, et al. "Interplay between IncF plasmids and topoisomerase mutations conferring quinolone resistance in the Escherichia coli ST131 clone: stability and resistance evolution." European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology vol. (2021). doi: https://doi.org/10.1007/s10096-021-04358-4
Rodríguez-Martínez JM, Lopez-Cerero L, García-Duque A, Rodriguez-Baño J, Pascual A. Interplay between IncF plasmids and topoisomerase mutations conferring quinolone resistance in the Escherichia coli ST131 clone: stability and resistance evolution. Eur J Clin Microbiol Infect Dis. 2021 Nov 17; doi: 10.1007/s10096-021-04358-4. Epub 2021 Nov 17. PMID: 34787748.
Copy Download .nbib Format: NLM
Use of antibiotics and factors associated with treatment failure among 152,245 patients with pneumonia treated in the community - a retrospective cohort study.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology

Reiner-Benaim A, Neuberger A, Chodick G, Henig O.
PMID: 34622350
Eur J Clin Microbiol Infect Dis. 2021 Oct 08; doi: 10.1007/s10096-021-04357-5. Epub 2021 Oct 08.

This study aims to evaluate risk factors associated with treatment failure and the antibiotics prescribed by primary care physicians in a large patient cohort treated for pneumonia in the community. A retrospective cohort study based on the databases of...

Cite
Reiner-Benaim A, Neuberger A, Chodick G, et al. Use of antibiotics and factors associated with treatment failure among 152,245 patients with pneumonia treated in the community - a retrospective cohort study. Eur J Clin Microbiol Infect Dis. 2021;doi: 10.1007/s10096-021-04357-5.
Reiner-Benaim, A., Neuberger, A., Chodick, G., & Henig, O. (2021). Use of antibiotics and factors associated with treatment failure among 152,245 patients with pneumonia treated in the community - a retrospective cohort study. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, . https://doi.org/10.1007/s10096-021-04357-5
Reiner-Benaim, A, et al. "Use of antibiotics and factors associated with treatment failure among 152,245 patients with pneumonia treated in the community - a retrospective cohort study." European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology vol. (2021). doi: https://doi.org/10.1007/s10096-021-04357-5
Reiner-Benaim A, Neuberger A, Chodick G, Henig O. Use of antibiotics and factors associated with treatment failure among 152,245 patients with pneumonia treated in the community - a retrospective cohort study. Eur J Clin Microbiol Infect Dis. 2021 Oct 08; doi: 10.1007/s10096-021-04357-5. Epub 2021 Oct 08. PMID: 34622350.
Copy Download .nbib Format: NLM
Impact of previous macrolide use on invasive pneumococcal disease due to erythromycin-resistant serotypes in adults over 59 years of age.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology

Chávez ACF, Comas LG, Espinosa LM, Lobo JY, de Provens OCP, Andrés JMA.
PMID: 34718890
Eur J Clin Microbiol Infect Dis. 2021 Oct 31; doi: 10.1007/s10096-021-04368-2. Epub 2021 Oct 31.

The major goals of the study were to describe the invasive pneumococcal disease (IPD) cases due to erythromycin-resistant serotypes and to evaluate the association between these cases and recent macrolide use in individuals aged over 59 years. We selected...

Cite
Chávez ACF, Comas LG, Espinosa LM, et al. Impact of previous macrolide use on invasive pneumococcal disease due to erythromycin-resistant serotypes in adults over 59 years of age. Eur J Clin Microbiol Infect Dis. 2021;doi: 10.1007/s10096-021-04368-2.
Chávez, A. C. F., Comas, L. G., Espinosa, L. M., Lobo, J. Y., de Provens, O. C. P., & Andrés, J. M. A. (2021). Impact of previous macrolide use on invasive pneumococcal disease due to erythromycin-resistant serotypes in adults over 59 years of age. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, . https://doi.org/10.1007/s10096-021-04368-2
Chávez, Abelardo Claudio Fernández, et al. "Impact of previous macrolide use on invasive pneumococcal disease due to erythromycin-resistant serotypes in adults over 59 years of age." European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology vol. (2021). doi: https://doi.org/10.1007/s10096-021-04368-2
Chávez ACF, Comas LG, Espinosa LM, Lobo JY, de Provens OCP, Andrés JMA. Impact of previous macrolide use on invasive pneumococcal disease due to erythromycin-resistant serotypes in adults over 59 years of age. Eur J Clin Microbiol Infect Dis. 2021 Oct 31; doi: 10.1007/s10096-021-04368-2. Epub 2021 Oct 31. PMID: 34718890.
Copy Download .nbib Format: NLM
Descending necrotizing mediastinitis from Ludwig's angina: a life-threatening condition.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology

Carrascosa MF, Cayón Hoyo S, Echeverría San-Sebastián R, Alcalde Díez I, Tapia Concha S, Campos Fernández S, Alonso-Fernández EM, González-Carrero Sixto C, Lobo Duro D, Sánchez Moreno L, Zabaleta-Murguiondo MÁ.
PMID: 34510302
Eur J Clin Microbiol Infect Dis. 2021 Sep 11; doi: 10.1007/s10096-021-04347-7. Epub 2021 Sep 11.

No abstract available.

Cite
Carrascosa MF, Cayón Hoyo S, Echeverría San-Sebastián R, et al. Descending necrotizing mediastinitis from Ludwig's angina: a life-threatening condition. Eur J Clin Microbiol Infect Dis. 2021;doi: 10.1007/s10096-021-04347-7.
Carrascosa, M. F., Cayón Hoyo, S., Echeverría San-Sebastián, R., Alcalde Díez, I., Tapia Concha, S., Campos Fernández, S., Alonso-Fernández, E. M., González-Carrero Sixto, C., Lobo Duro, D., Sánchez Moreno, L., & Zabaleta-Murguiondo, M. �. �. (2021). Descending necrotizing mediastinitis from Ludwig's angina: a life-threatening condition. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, . https://doi.org/10.1007/s10096-021-04347-7
Carrascosa, Miguel F, et al. "Descending necrotizing mediastinitis from Ludwig's angina: a life-threatening condition." European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology vol. (2021). doi: https://doi.org/10.1007/s10096-021-04347-7
Carrascosa MF, Cayón Hoyo S, Echeverría San-Sebastián R, Alcalde Díez I, Tapia Concha S, Campos Fernández S, Alonso-Fernández EM, González-Carrero Sixto C, Lobo Duro D, Sánchez Moreno L, Zabaleta-Murguiondo MÁ. Descending necrotizing mediastinitis from Ludwig's angina: a life-threatening condition. Eur J Clin Microbiol Infect Dis. 2021 Sep 11; doi: 10.1007/s10096-021-04347-7. Epub 2021 Sep 11. PMID: 34510302.
Copy Download .nbib Format: NLM
Seasonal variations in blood culture numbers and time to positivity and potential impact of reducing incubation periods.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology

de Ponfilly GP, Lourtet-Hascoet J, Porcheret H, Cambau E, Le Monnier A, Jacquier H, Vasse M, Farfour E.
PMID: 33893569
Eur J Clin Microbiol Infect Dis. 2021 Oct;40(10):2087-2093. doi: 10.1007/s10096-021-04248-9. Epub 2021 Apr 23.

Patients with viral respiratory infections often present symptoms compatible with bloodstream infections. Consequently, the winter period commonly associated with epidemic respiratory illnesses shows an increase in the number of blood cultures (BC) and to occasional saturation of automated BC...

Cite
de Ponfilly GP, Lourtet-Hascoet J, Porcheret H, et al. Seasonal variations in blood culture numbers and time to positivity and potential impact of reducing incubation periods. Eur J Clin Microbiol Infect Dis. 2021;40(10):2087-2093doi: 10.1007/s10096-021-04248-9.
de Ponfilly, G. P., Lourtet-Hascoet, J., Porcheret, H., Cambau, E., Le Monnier, A., Jacquier, H., Vasse, M., & Farfour, E. (2021). Seasonal variations in blood culture numbers and time to positivity and potential impact of reducing incubation periods. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 40(10), 2087-2093. https://doi.org/10.1007/s10096-021-04248-9
de Ponfilly, Gauthier Péan, et al. "Seasonal variations in blood culture numbers and time to positivity and potential impact of reducing incubation periods." European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology vol. 40,10 (2021): 2087-2093. doi: https://doi.org/10.1007/s10096-021-04248-9
de Ponfilly GP, Lourtet-Hascoet J, Porcheret H, Cambau E, Le Monnier A, Jacquier H, Vasse M, Farfour E. Seasonal variations in blood culture numbers and time to positivity and potential impact of reducing incubation periods. Eur J Clin Microbiol Infect Dis. 2021 Oct;40(10):2087-2093. doi: 10.1007/s10096-021-04248-9. Epub 2021 Apr 23. PMID: 33893569; PMCID: PMC8064422.
Copy Download .nbib Format: NLM
Comparative activity of plazomicin against extended-spectrum cephalosporin-resistant Escherichia coli clinical isolates (2012-2017) in relation to phylogenetic background, sequence type 131 subclones, bla.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology

Johnston BD, Thuras P, Porter SB, Clabots C, Johnson JR.
PMID: 33893571
Eur J Clin Microbiol Infect Dis. 2021 Oct;40(10):2069-2075. doi: 10.1007/s10096-021-04256-9. Epub 2021 Apr 23.

Extended-spectrum cephalosporin-resistant Escherichia coli (ESCREC) are a growing threat. Leading ESCREC lineages include sequence type ST131, especially its (bla

Cite
Johnston BD, Thuras P, Porter SB, et al. Comparative activity of plazomicin against extended-spectrum cephalosporin-resistant Escherichia coli clinical isolates (2012-2017) in relation to phylogenetic background, sequence type 131 subclones, bla. Eur J Clin Microbiol Infect Dis. 2021;40(10):2069-2075doi: 10.1007/s10096-021-04256-9.
Johnston, B. D., Thuras, P., Porter, S. B., Clabots, C., & Johnson, J. R. (2021). Comparative activity of plazomicin against extended-spectrum cephalosporin-resistant Escherichia coli clinical isolates (2012-2017) in relation to phylogenetic background, sequence type 131 subclones, bla. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 40(10), 2069-2075. https://doi.org/10.1007/s10096-021-04256-9
Johnston, Brian D, et al. "Comparative activity of plazomicin against extended-spectrum cephalosporin-resistant Escherichia coli clinical isolates (2012-2017) in relation to phylogenetic background, sequence type 131 subclones, bla." European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology vol. 40,10 (2021): 2069-2075. doi: https://doi.org/10.1007/s10096-021-04256-9
Johnston BD, Thuras P, Porter SB, Clabots C, Johnson JR. Comparative activity of plazomicin against extended-spectrum cephalosporin-resistant Escherichia coli clinical isolates (2012-2017) in relation to phylogenetic background, sequence type 131 subclones, bla. Eur J Clin Microbiol Infect Dis. 2021 Oct;40(10):2069-2075. doi: 10.1007/s10096-021-04256-9. Epub 2021 Apr 23. PMID: 33893571; PMCID: PMC8449799.
Copy Download .nbib Format: NLM
Prevalence and serotyping of S. pneumoniae in a large vaccine-naive cohort of adults with cystic fibrosis.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology

Gramegna A, Aliberti S, Terranova L, Oriano M, Contarini M, Blasi F.
PMID: 33937933
Eur J Clin Microbiol Infect Dis. 2021 Nov;40(11):2443-2446. doi: 10.1007/s10096-021-04263-w. Epub 2021 May 03.

We conducted a prospective, observational study at the Adult CF Center, Ospedale Policlinico, Milano, Italy, from March 2017 to September 2019 to assess the prevalence and serotypes of Streptococcus pneumoniae (SP) in adults with CF naive to pneumococcal vaccination....

Cite
Gramegna A, Aliberti S, Terranova L, et al. Prevalence and serotyping of S. pneumoniae in a large vaccine-naive cohort of adults with cystic fibrosis. Eur J Clin Microbiol Infect Dis. 2021;40(11):2443-2446doi: 10.1007/s10096-021-04263-w.
Gramegna, A., Aliberti, S., Terranova, L., Oriano, M., Contarini, M., & Blasi, F. (2021). Prevalence and serotyping of S. pneumoniae in a large vaccine-naive cohort of adults with cystic fibrosis. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 40(11), 2443-2446. https://doi.org/10.1007/s10096-021-04263-w
Gramegna, Andrea, et al. "Prevalence and serotyping of S. pneumoniae in a large vaccine-naive cohort of adults with cystic fibrosis." European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology vol. 40,11 (2021): 2443-2446. doi: https://doi.org/10.1007/s10096-021-04263-w
Gramegna A, Aliberti S, Terranova L, Oriano M, Contarini M, Blasi F. Prevalence and serotyping of S. pneumoniae in a large vaccine-naive cohort of adults with cystic fibrosis. Eur J Clin Microbiol Infect Dis. 2021 Nov;40(11):2443-2446. doi: 10.1007/s10096-021-04263-w. Epub 2021 May 03. PMID: 33937933.
Copy Download .nbib Format: NLM
Carriage of ESBL-producing Enterobacterales in wastewater treatment plant workers and surrounding residents - the AWARE Study.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology

Rodríguez-Molina D, Berglund F, Blaak H, Flach CF, Kemper M, Marutescu L, Gradisteanu GP, Popa M, Spießberger B, Weinmann T, Wengenroth L, Chifiriuc MC, Larsson DGJ, Nowak D, Radon K, de Roda Husman AM, Wieser A, Schmitt H.
PMID: 34902088
Eur J Clin Microbiol Infect Dis. 2021 Dec 13; doi: 10.1007/s10096-021-04387-z. Epub 2021 Dec 13.

To investigate whether wastewater treatment plant (WWTP) workers and residents living in close proximity to a WWTP have elevated carriage rates of ESBL-producing Enterobacterales, as compared to the general population. From 2018 to 2020, we carried out a cross-sectional...

Cite
Rodríguez-Molina D, Berglund F, Blaak H, et al. Carriage of ESBL-producing Enterobacterales in wastewater treatment plant workers and surrounding residents - the AWARE Study. Eur J Clin Microbiol Infect Dis. 2021;doi: 10.1007/s10096-021-04387-z.
Rodríguez-Molina, D., Berglund, F., Blaak, H., Flach, C. F., Kemper, M., Marutescu, L., Gradisteanu, G. P., Popa, M., Spießberger, B., Weinmann, T., Wengenroth, L., Chifiriuc, M. C., Larsson, D. G. J., Nowak, D., Radon, K., de Roda Husman, A. M., Wieser, A., & Schmitt, H. (2021). Carriage of ESBL-producing Enterobacterales in wastewater treatment plant workers and surrounding residents - the AWARE Study. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, . https://doi.org/10.1007/s10096-021-04387-z
Rodríguez-Molina, Daloha, et al. "Carriage of ESBL-producing Enterobacterales in wastewater treatment plant workers and surrounding residents - the AWARE Study." European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology vol. (2021). doi: https://doi.org/10.1007/s10096-021-04387-z
Rodríguez-Molina D, Berglund F, Blaak H, Flach CF, Kemper M, Marutescu L, Gradisteanu GP, Popa M, Spießberger B, Weinmann T, Wengenroth L, Chifiriuc MC, Larsson DGJ, Nowak D, Radon K, de Roda Husman AM, Wieser A, Schmitt H. Carriage of ESBL-producing Enterobacterales in wastewater treatment plant workers and surrounding residents - the AWARE Study. Eur J Clin Microbiol Infect Dis. 2021 Dec 13; doi: 10.1007/s10096-021-04387-z. Epub 2021 Dec 13. PMID: 34902088; PMCID: PMC8667530.
Copy Download .nbib Format: NLM
Fatal Pandoraea nosoerga infection after combined liver-lung transplantation for cystic fibrosis: a recontamination by the pre-transplantation strain.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology

Peyclit L, Baron SA, Reynaud-Gaubert M, Cassir N, Rolain JM.
PMID: 33830365
Eur J Clin Microbiol Infect Dis. 2021 Nov;40(11):2403-2406. doi: 10.1007/s10096-021-04235-0. Epub 2021 Apr 08.

A 26-year-old girl with a longstanding colonization by Pandoraea nosoerga underwent liver-lung transplantation for cystic fibrosis (CF) in 2018. Her brother also suffering from CF was also colonized by P. nosoerga. Despite appropriate perioperative antibiotic therapy, she had post-transplant...

Cite
Peyclit L, Baron SA, Reynaud-Gaubert M, et al. Fatal Pandoraea nosoerga infection after combined liver-lung transplantation for cystic fibrosis: a recontamination by the pre-transplantation strain. Eur J Clin Microbiol Infect Dis. 2021;40(11):2403-2406doi: 10.1007/s10096-021-04235-0.
Peyclit, L., Baron, S. A., Reynaud-Gaubert, M., Cassir, N., & Rolain, J. M. (2021). Fatal Pandoraea nosoerga infection after combined liver-lung transplantation for cystic fibrosis: a recontamination by the pre-transplantation strain. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 40(11), 2403-2406. https://doi.org/10.1007/s10096-021-04235-0
Peyclit, Lucie, et al. "Fatal Pandoraea nosoerga infection after combined liver-lung transplantation for cystic fibrosis: a recontamination by the pre-transplantation strain." European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology vol. 40,11 (2021): 2403-2406. doi: https://doi.org/10.1007/s10096-021-04235-0
Peyclit L, Baron SA, Reynaud-Gaubert M, Cassir N, Rolain JM. Fatal Pandoraea nosoerga infection after combined liver-lung transplantation for cystic fibrosis: a recontamination by the pre-transplantation strain. Eur J Clin Microbiol Infect Dis. 2021 Nov;40(11):2403-2406. doi: 10.1007/s10096-021-04235-0. Epub 2021 Apr 08. PMID: 33830365.
Copy Download .nbib Format: NLM
An evaluation of the Unyvero pneumonia system for rapid detection of microorganisms and resistance markers of lower respiratory infections-a multicenter prospective study on ICU patients.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology

Sun L, Li L, Du S, Liu Y, Cao B.
PMID: 33934275
Eur J Clin Microbiol Infect Dis. 2021 Oct;40(10):2113-2121. doi: 10.1007/s10096-021-04259-6. Epub 2021 May 01.

Rapid diagnosis of microorganisms and antibiotic resistance is vital for the appropriate treatment of patients with lower respiratory infections, especially for patients in Intensive Care Unit. We conducted a multicenter prospective study to evaluate the ability of the Unyvero...

Cite
Sun L, Li L, Du S, et al. An evaluation of the Unyvero pneumonia system for rapid detection of microorganisms and resistance markers of lower respiratory infections-a multicenter prospective study on ICU patients. Eur J Clin Microbiol Infect Dis. 2021;40(10):2113-2121doi: 10.1007/s10096-021-04259-6.
Sun, L., Li, L., Du, S., Liu, Y., & Cao, B. (2021). An evaluation of the Unyvero pneumonia system for rapid detection of microorganisms and resistance markers of lower respiratory infections-a multicenter prospective study on ICU patients. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 40(10), 2113-2121. https://doi.org/10.1007/s10096-021-04259-6
Sun, Lingxiao, et al. "An evaluation of the Unyvero pneumonia system for rapid detection of microorganisms and resistance markers of lower respiratory infections-a multicenter prospective study on ICU patients." European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology vol. 40,10 (2021): 2113-2121. doi: https://doi.org/10.1007/s10096-021-04259-6
Sun L, Li L, Du S, Liu Y, Cao B. An evaluation of the Unyvero pneumonia system for rapid detection of microorganisms and resistance markers of lower respiratory infections-a multicenter prospective study on ICU patients. Eur J Clin Microbiol Infect Dis. 2021 Oct;40(10):2113-2121. doi: 10.1007/s10096-021-04259-6. Epub 2021 May 01. PMID: 33934275.
Copy Download .nbib Format: NLM
Showing 25 to 36 of 222 entries